| P50 | author | Kooresh I. Shoghi | Q40124057 |
| | Samuel T Nemanich | Q40670225 |
| P2093 | author name string | Sudheer Rani | |
| P2860 | cites work | Preliminary evaluation of 15-[18F]fluoro-3-oxa-pentadecanoate as a PET tracer of hepatic fatty acid oxidation. | Q51553114 |
| | Hyperglycemia contributes insulin resistance in hepatic and adipose tissue but not skeletal muscle of ZDF rats. | Q51557784 |
| | Intramuscular triglyceride and muscle insulin sensitivity: evidence for a relationship in nondiabetic subjects. | Q51580403 |
| | The action of insulin on brown adipose tissuein vivo | Q51680681 |
| | BAT: a new target for human obesity? | Q53344276 |
| | Effects of troglitazone on substrate storage and utilization in insulin-resistant rats. | Q54093005 |
| | Glucose transport deficiency in diabetic animals is corrected by treatment with the oral antihyperglycemic agent pioglitazone. | Q54287151 |
| | The missing link with obesity? | Q59054307 |
| | Increased rates of fatty acid uptake and plasmalemmal fatty acid transporters in obese Zucker rats | Q74371834 |
| | Tissue-specific effects of rosiglitazone and exercise in the treatment of lipid-induced insulin resistance | Q80171915 |
| | Obesity and insulin resistance | Q24607078 |
| | Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations | Q28236042 |
| | Brown adipose tissue-specific insulin receptor knockout shows diabetic phenotype without insulin resistance | Q28361848 |
| | Thiazolidinediones: a new class of antidiabetic drugs | Q33607634 |
| | Brown fat as a therapy for obesity and diabetes | Q34099153 |
| | Diabetes mellitus and coronary heart disease | Q34451762 |
| | Imaging myocardium enzymatic pathways with carbon-11 radiotracers | Q35766468 |
| | Basic disturbances in skeletal muscle fatty acid metabolism in obesity and type 2 diabetes mellitus | Q35855979 |
| | Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis | Q35995063 |
| | Time course of alterations in myocardial glucose utilization in the Zucker diabetic fatty rat with correlation to gene expression of glucose transporters: a small-animal PET investigation | Q40123899 |
| | Thermogenic mechanisms in brown fat | Q40140016 |
| | In vivo metabolic phenotyping of myocardial substrate metabolism in rodents: differential efficacy of metformin and rosiglitazone monotherapy | Q41832683 |
| | Insulin-sensitizing effect of rosiglitazone (BRL-49653) by regulation of glucose transporters in muscle and fat of Zucker rats | Q42512578 |
| | A method to quantify glucose utilization in vivo in skeletal muscle and white adipose tissue of the anaesthetized rat. | Q42849642 |
| | Cardiac and skeletal muscle fatty acid transport and transporters and triacylglycerol and fatty acid oxidation in lean and Zucker diabetic fatty rats | Q43292829 |
| | Effects of pioglitazone on adipose tissue remodeling within the setting of obesity and insulin resistance | Q43687860 |
| | Interactions of impaired glucose transport and phosphorylation in skeletal muscle insulin resistance: a dose-response assessment using positron emission tomography | Q43719966 |
| | Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes | Q43833528 |
| | Glucose uptake, glucose transporter GLUT4, and glycolytic enzymes in brown adipose tissue from rats adapted to a high-protein diet. | Q44197044 |
| | Glucose transport and phosphorylation in skeletal muscle in obesity: insight from a muscle-specific positron emission tomography model | Q44357258 |
| | Effects of metformin and rosiglitazone monotherapy on insulin-mediated hepatic glucose uptake and their relation to visceral fat in type 2 diabetes | Q44495251 |
| | Tissue-specific differences in 2-fluoro-2-deoxyglucose metabolism beyond FDG-6-P: a 19F NMR spectroscopy study in the rat. | Q44706590 |
| | Enhancement of insulin-stimulated myocardial glucose uptake in patients with Type 2 diabetes treated with rosiglitazone | Q45166060 |
| | In obese rat muscle transport of palmitate is increased and is channeled to triacylglycerol storage despite an increase in mitochondrial palmitate oxidation | Q46164599 |
| | Divergent effects of rosiglitazone on protein-mediated fatty acid uptake in adipose and in muscle tissues of Zucker rats | Q46384606 |
| | Rosiglitazone increases fatty acid oxidation and fatty acid translocase (FAT/CD36) but not carnitine palmitoyltransferase I in rat muscle mitochondria | Q46779978 |
| | Insulin resistance in the Zucker diabetic fatty rat: a metabolic characterisation of obese and lean phenotypes | Q46871359 |
| | Contribution of organ blood flow, intrinsic tissue clearance and glycaemia to the regulation of glucose use in obese and type 2 diabetic rats: a PET study. | Q51376372 |
| | Performance evaluation of the microPET focus: a third-generation microPET scanner dedicated to animal imaging. | Q51532478 |
| P433 | issue | 12 | |
| P921 | main subject | obesity | Q12174 |
| | fatty acid | Q61476 |
| P304 | page(s) | 2522-2529 | |
| P577 | publication date | 2013-05-31 | |
| P1433 | published in | Obesity | Q15763232 |
| P1476 | title | In vivo multi-tissue efficacy of peroxisome proliferator-activated receptor-γ therapy on glucose and fatty acid metabolism in obese type 2 diabetic rats | |
| P478 | volume | 21 | |